BioSpace News Archive

BioLife Sciences Inc. (OTCPK:BLFE) announces it has initiated the process of up-listing to the Over the Counter Quotation Bureau (“OTCQB®”) by engaging MNP LLP (“MNP”), an accounting firm registered with the U.S Public Company Accounting Oversighting Board (“PCAOB”), to independently audit BioLife’s finances.

Beroni Group, an Australia-based diversified biopharmaceutical enterprise announced that the Company has been recognized as one of the 2020’s infection control solutions companies in Asia Pacific by MedTech Outlook.

Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate

BrainTale, a French innovative company dedicated to enabling adapted care for brain injured patients in clinical routine with its portfolio of quantification and prediction digital medical devices in neurology and intensive care, announced the completion of its first financing round securing more than 1M€ of funding.

Customized cell analyzer installed in Naples, Italy for biomedical research and water monitoring

IND filing today for STI-2020 (COVI-AMG™) for the treatment of COVID-19 in patients with mild symptoms and a separate safety and pharmacokinetic study in healthy volunteers. These initial trials are expected to be followed by pivotal trials with a goal of potentially receiving an EUA (Emergency Use Authorization). Animal model data (golden Syrian hamsters infected with SARS-CoV-2) demonstrated a highly effective neutralizing profile.

Cerner Corporation, a global health care technology company, announced it has been named among 2020’s World’s Best Employers by Forbes.

Neurocrine Biosciences, Inc. announced that Neurocrine Biosciences management will present at the following investor conferences

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced the appointment of Steve Mahoney as Chief Financial and Operating Officer. “We welcome Steve to Magenta as a seasoned biotech executive with a strong leadership background,” said Jason Gardner, D.Phil., Chief Executive Officer and Pre

UroGen Pharma Ltd.today announced financial results for the third quarter ended September 30, 2020 and provided an overview of the Company’s recent developments.